U.S. PRP and Stem Cell Alopecia Treatment Market Worth $183.3 Million By 2025

The U.S. PRP and stem cell alopecia treatment market size is expected to reach USD 183.3 million by 2025 at a 5.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing positive patient outcome. Moreover, lower incidences of negative side effects due to this therapy is anticipated to fuel demand for platelet rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to rise in number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.

By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.

The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/us-platelet-rich-plasma-prp-stem-cell-alopecia-treatment-market

Further key findings from the report suggest:

• PRP procedures dominated the market in terms of volume in 2017, owing to its safety, effectiveness, and minimal chances of failure
• Stem cell therapy accounted for the dominant revenue share in 2017 owing to higher prices of PRP procedures as compared to stem cell therapy. The segment was valued at USD 70.1 million in 2017
• The dermatology clinic segment held the largest revenue share in 2017, accounting for USD 105.2 million
• Some of the clinics providing PRP and stem cell therapy for alopecia in this market are Hair Sciences Center of Colorado, Anderson Center, PLC, Nova Genix, and Hair Transplant Institute of Miami.